In this study, we evaluated the efficacy of the discharge Acute Physiology and Chronic Health Evaluation (APACHE) II score in predicting post-intensive care unit (ICU) mortality and ICU readmission during the same hospitalisation in a surgical ICU. Of 1190 patients who were admitted to the ICU and stayed >48 hours between October 2007 and March 2010, 23 (1.9%) died and 86 (7.2%) were readmitted after initial ICU discharge, with 26 (3.0%) admitted within 48 hours. The area under the receiver operating characteristics curve of the discharge and admission APACHE II scores in predicting in-hospital mortality was 0.631 (95% confidence interval [CI] 0.603 to 0.658) and 0.669 (95% CI 0.642 to 0.696), respectively (P=0.510). The area under the receiver operating characteristics curve of discharge and admission APACHE II scores for predicting all forms of readmission was 0.606 (95% CI 0.578 to 0.634) and 0.574 (95% CI 0.545 to 0.602), respectively (P=0.316). The area under the receiver operating characteristics curve of discharge APACHE II score in predicting early ICU readmissions was, however, higher than that of admission APACHE II score (0.688 [95% CI 0.660 to 0.714] versus 0.505 [95% CI 0.476 to 0.534], P=0.001). The discharge APACHE II score (odds ratio [OR] 1.1, 95% CI 1.01 to 1.22, P=0.024), unplanned ICU readmission (OR 20.0, 95% CI 7.6 to 53.1, P=0.001), eosinopenia at ICU discharge (OR 6.0, 95% CI 1.34 to 26.9, P=0.019), and hospital length-of-stay before ICU admission (OR 1.02, 95% CI 1.01 to 1.03, P=0.021) were significant independent factors in predicting post-ICU mortality. This study suggests that the discharge APACHE II score may be useful in predicting post-ICU mortality and is superior to the admission APACHE II score in predicting early ICU readmission in surgical ICU patients.
Intensive care unit (ICU) readmission and post-ICU mortality are two major severe adverse events following successful discharge from ICUs 1 . Recent studies have shown that the rates of those adverse outcomes range from 6.5% to 17.5% [2] [3] [4] . A number of risk factors associated with adverse outcomes include age, comorbid conditions, severity of illness at ICU admission, eosinopenia at ICU discharge, nocturnal discharge, unstable vital signs at ICU discharge, unplanned discharge, inadequate care on ward and development of new serious problems [2] [3] [4] [5] [6] [7] [8] . Various objective scoring systems such as the Stability and Workload Index for Transfer (SWIFT) score 9 , the ICU discharge readiness score 10 and the Minimizing ICU Readmission score 3 have been introduced to reduce post-ICU mortality and ICU readmission. However, their external validities have not yet been well established.
The Acute Physiology and Chronic Health Evaluation (APACHE) II model has been used in many ICUs across the world since 1985 because of its simplicity and capability of classifying severity of illness and predicting hospital mortality [11] [12] [13] [14] . There are two types of APACHE II scores based on the timing of measurement. The admission APACHE II score is usually measured during the first 24 hours after admission to the ICU, whereas the discharge APACHE II score is measured during the 24 hours before ICU discharge. Previous reports have shown that the admission APACHE II score is associated with ICU readmission and post-ICU mortality 12, 15 . However, the admission APACHE II score does not include medical treatment or the subsequent course of critical illness after the first 24 hours in the ICU and its validity has been challenged 16 . Lee et al found that the discharge APACHE II score was a significant predictor of ICU readmission in neurosurgical ICU patients 14 .
Additionally, recent studies suggested that the discharge APACHE II score may be helpful in identifying patients at high risk of mortality after medical ICU discharge 11, 17 . We hypothesised that the discharge APACHE II score would be superior to the admission APACHE II score in predicting post-ICU mortality and ICU readmission in surgical ICU (SICU) patients.
Materials and methods
This retrospective study was approved by the Institutional Review Board of Seoul National University Hospital (Approval No. H1006-051-321) and informed consent was waived. This study was conducted in the SICU of a 1200-bed university teaching hospital. The SICU, which comprised 32 beds, was operated by an open system. An intensivist, a fellow in intensive care medicine and a senior anaesthesia resident provided daytime coverage. Postoperative vascular, thoracic, orthopaedic, general surgical and neurosurgical patients, as well as complex surgical patients transferred from other hospitals, were mainly admitted to the SICU. Patients with serious medical or surgical postoperative complications, irrespective of cause, were allowed admission to the SICU.
We reviewed the medical records of all patients admitted to the SICU from October 2007 to March 2010. Cardiac and paediatric patients, and patients who were scheduled to be readmitted to the SICU due to planned or staged operation, were excluded. We also excluded patients with a SICU stay of <48 hours or >30 days and with readmission after 30 days from initial ICU discharge. Finally, patients who died during the initial ICU stay, those who were discharged for palliative care or transferred to other ICUs, and cadaveric donors were excluded from data analysis ( Figure 1) .
The database contained demographic and clinical data including age, sex, initial admission diagnoses, admission routes and types, discharge destination, comorbidities, admission and discharge APACHE II scores, nocturnal discharge (1800 to 0800 h), mechanical ventilation, unplanned ICU readmission, the time interval between the initial ICU discharge and readmission, C-reactive protein concentrations and eosinophil counts within 24 hours of ICU discharge, the use of vasopressor and haemodialysis, lengths of ICU and hospital stay (LOS), readmission diagnoses, causes of death and survival status at hospital discharge. High-sensitivity C-reactive protein concentrations were measured using the Turbid immuno assay (TBA-200FR, Toshiba Medical Systems, Tokyo, Japan). Eosinophil counts were performed using an automated haematology analyser (XE-2100, Sysmex, Kobe, Japan). The admission and discharge APACHE II scores were derived from the worst vital signs and laboratory findings obtained 24 hours after admission and 24 hours before discharge, respectively. Eosinopenia was defined as eosinophil counts <0.01×10 3 /µl. Early ICU readmission was defined as ICU readmission within 48 hours after initial ICU discharge. Admission routes were classified to operating room, general ward, emergency room and other ICU. Admission types were categorised into elective surgery, emergency surgery and nonsurgery. Initial admission diagnoses were classified into postoperative care, respiratory and neurologic problems, cardiovascular instability, postoperative bleeding, gastrointestinal problems, sepsis and others. Based upon primary causes of readmission, the diagnoses for readmission were categorised into respiratory problems, neurologic deterioration, surgical complications such as postoperative bleeding, gastrointestinal problems such as upper or lower gastrointestinal bleeding and ileus, sepsis and others such as severe arrhythmia and postcardiopulmonary resuscitation. In patients with more than one ICU readmission, only data for the first readmission were included in the data analysis.
Statistical Discharge APACHE II scores showed collinearity with discharge acute physiology scores and discharge APACHE II-predicted mortality (Pearson`s correlation coefficient 0.820, 0.963). Therefore, we chose the admission and discharge APACHE II scores in univariate and multivariate analyses. To access the discrimination ability of admission and discharge APACHE II scores to predict post-ICU mortality, ICU readmission and early readmission, the area under the receiver operating characteristic (AUROC) curve was used. If a statistical significance was observed in the AUROC curve, Youden index (max [sensitivity + specificity -1]), a function of sensitivity and specificity, was used to determine the optimal cut-off point for the discharge APACHE II score 14 . Calibration of discharge APACHE II scores in predicting post-ICU mortality, ICU readmission and early readmission was assessed using the HosmerLemeshow goodness-of-fit test 18 . P-values <0.05 were considered statistically significant. 
Results
A total of 4953 patients were admitted to SICU during the study period. We excluded 3763 (76.0%) patients (70 organ donors, 149 medical patients, 119 paediatric patients, 83 patients who died during their initial ICU admission, 62 with ICU LOS >30 days, 88 patients transferred to another ICU, 3115 with a LOS in ICU <48 hours, 57 with a planned readmission after a staged operation and 20 patients readmitted after 30 days from the initial ICU discharge). Finally, 1190 patients were enrolled in the data analysis ( Figure 1) .
Of the 1190 patients, 23 (1.9%) died after the initial ICU discharge. Post-ICU non-survivors had higher admission APACHE II scores (22 versus Table 2) .
The AUROC curve of the discharge APACHE II score for predicting post-ICU mortality was 0.631 (95% CI 0.603 to 0.658) and its cut-off point of 14 had a sensitivity of 0.610 and a specificity of 0.660. The AUROC curve of the admission APACHE II score was 0.669 (95% CI 0.642 to 0.696) and was not different from that of the discharge APACHE II score (P=0.510). Calibration of the discharge APACHE II score for predicting post-ICU mortality was good (H-statistics=6.060, P=0.641).
During the study period, a total of 86 (7.2%) patients were readmitted unexpectedly. The median time interval between the initial ICU discharge and readmission was three days (interquartile range 1 to 7 days). Readmitted patients had higher admission APACHE II scores (20 versus 17, P=0.022) and discharge APACHE II scores (13 versus 11, P=0.001) than those who were not readmitted (Table 3) . Vasopressor support was more common in readmitted patients (37.2 versus 23.5%, P=0.006). Readmitted patients had a longer ICU and hospital LOS and a higher mortality rate than those who were not readmitted. In multivariate logistic regression analysis, discharge APACHE II score (OR 1.06, 95% CI 1.01 to 1.10, P=0.015), respiratory problem at admission (OR 3.1, 95% CI 1.4 to 6.9, P=0.004) and vasopressor use during ICU stay (OR 1.7, 95% CI 1.09 to 2.8, P=0.022) were significant predictors of ICU readmission after adjusting for age, admission routes, admission types, admission APACHE II scores and ICU LOS ( Table 4 ). The AUROC curve of the discharge APACHE II score for predicting ICU readmission was 0.606 (95% CI 0.578 to 0.634) and its cut-off point of 15 had a sensitivity of 0.440 and a specificity of 0.730. The AUROC curve of the admission APACHE II score was 0.574 (95% CI 0.545 to 0.602) and was not statistically different from that of the discharge APACHE II score (P=0.316). The discharge APACHE II score showed good calibration in predicting ICU readmission (H-statistics=10.465, P=0.234).
Among the 86 readmitted patients, 26 (30.2%) had an early ICU readmission. The discharge APACHE II score was higher in patients with early readmission than in patients without (15 versus 12, P=0.001, Table 5 ). Discharge APACHE II score (OR 1.1, 95% CI 1.05 to 1.21, P=0.001) and metastatic cancer (OR 3.2, 95%CI 1.2 to 8.9, P=0.025) were both predictive of early ICU readmission (Table 6 ). The AUROC curve of the discharge APACHE II score in predicting early ICU readmission was 0.688 (95% CI 0.660 to 0.714, Figure 2 ), which was significantly higher than that of the admission APACHE II score (0.505, 95% CI 0.476 to 0.534, P <0.001). Its cut-off point of 15 had a sensitivity of 0.577 and a specificity of 0.731. The discharge APACHE II score showed good calibration in predicting early ICU readmission (H-statistics=4.511, P=0.808). 
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Discussion
In this study, we found that 1) the discharge APACHE II score was an independent predictor of post-ICU mortality, unplanned ICU readmission and early ICU readmission during the same hospitalisation in SICU patients and 2) the discharge APACHE II score had a better discrimination in predicting early ICU readmission than the admission APACHE II score.
It is important to avoid unexpected in-hospital mortality and ICU readmission after ICU discharge. Traditionally, making a decision for ICU discharge has been dependent on the clinical judgement of an ICU physician under agreement with a physician in the service department. Various tools, such as the SWIFT score 9 , ICU discharge readiness score 10 and Minimising ICU Readmission score 3 , were increasingly used to evaluate patients' risks at the time of ICU discharge, but currently, there is no consensus on the best tool to use to facilitate ICU discharge. In this study, we focused on the discharge APACHE II score and evaluated its efficacy in predicting post-ICU mortality and ICU readmissions. Our results showed that the discharge APACHE II score, not the admission APACHE II score, was an independent predictor of post-ICU mortality and ICU readmission. In accordance with our study, several studies in neurosurgical and medical ICU patients demonstrated that the discharge APACHE II score may be helpful to predict post-ICU mortality and ICU readmission 11, 14, 17 . Early ICU readmission is an important clinical indicator reflecting the quality of ICU care. Early readmission may indicate that patients were discharged prematurely from ICUs. Interestingly, this study showed that the discharge APACHE II score was significantly higher in patients with early ICU readmission than those without early ICU readmission, whereas the admission APACHE II score was comparable in both patients with and without early ICU readmission. Moreover, the discharge APACHE II score was a predictive factor of early ICU readmission in multivariate logistic analysis. The discriminating ability of the discharge APACHE II score to predict early ICU readmission was significantly better than that of the admission APACHE II score. Such findings suggest that the discharge APACHE II score is superior to the admission APACHE II score in predicting early ICU readmission.
In this study, the discrimination ability, which is measured by the AUROC curve to predict post-ICU mortality and ICU readmission, was moderate for the discharge APACHE II score. Also, the discrimination ability of the discharge APACHE II score to predict both adverse events was not statistically different from that of the admission APACHE II score. Similar to our result, a previous study demonstrated that the discharge APACHE II score was associated with post-ICU mortality but the discrimination ability to predict post-ICU mortality was comparable in both admission and discharge APACHE II scores 11 . In addition to the discharge APACHE II score, this study showed that unplanned ICU readmission was the strongest risk factor of post-ICU mortality. Similar to our study, most previous studies demonstrated that post-ICU mortality was significantly higher in readmitted patients than in nonreadmitted patients and readmission itself was a significant predictor of hospital mortality 5, [19] [20] [21] [22] . In this study, eosinopenia at ICU discharge was also found to be associated with post-ICU mortality and ICU readmission, consistent with findings from other studies suggesting that occult infection remains a possible cause of adverse events near the time of ICU discharge 2, 23 .
In agreement with previous studies [24] [25] [26] , this study showed that respiratory distress, as a diagnostic criterion at ICU admission, was associated with ICU readmission and postoperative respiratory complications were the most common cause of ICU readmission. In particular, hypoxaemia resulting from ineffective expectoration was observed in 41% of patients with ICU readmission due to respiratory complications. Rosenberg et al also showed that inadequate respiratory care was related to pulmonary causes for readmission 27 . Moreover, other studies have shown that establishing a dedicated team of respiratory therapists may decrease the premature transfer out of the ICU that may result in early readmission 24, 28 . These studies and our findings suggest that aggressive pulmonary hygiene during the recovery phase of critical illness may decrease the incidence of readmission and improve outcomes after ICU discharge.
There are several limitations in this study. Firstly, this study was conducted in a single SICU, which limits the ability to generalise the results to other ICUs such as medical or mixed medico-surgical ICUs. Secondly, we included only readmissions to the SICU after initial SICU discharge. Readmissions to other ICUs after the initial SICU discharge were not included. Thirdly, considering SICU patients' characteristics, many patients who had an ICU stay of less than 48 hours were not included in this study because at least 48 hours of ICU stay were needed to calculate discharge APACHE II scores. Finally, with respect to predicting post-ICU mortality and ICU readmission, we did not compare the efficacy of the discharge APACHE II score with those of other scoring systems such as the Sequential Organ Failure Assessment score at discharge, the Therapeutic Intervention Scoring System, and the SWIFT score; whether or not one score is better than the others remains uncertain.
Conclusion
In conclusion, this study showed that the discharge APACHE II score, not the admission APACHE II score, was an independent predictive factor of post-ICU mortality and ICU readmission, especially early ICU readmission in SICU patients. The discrimination ability of the discharge APACHE II score to predict early ICU readmission was significantly better than that of the admission APACHE II score. This study suggests that discharge APACHE II scores may be useful in stratifying patients' risk at the time of ICU discharge.
